A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Anemia · Iron Deficiencies · Chronic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nucleus Network, Melbourne, Victoria, Australia

Study leads

Aarthy Joseph, Dr
Principal Investigator
Nucleus Network

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Anemia · Chronic Kidney Disease · Chronic Kidney Disease Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Minsk, Belarus · Saint Petersburg, Russia

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Acute Myeloid Leukemia · Neutropenia · Anemia

Abroad (travel likely)RecruitingPHASE1

Wuhan, China

Biocollection in MyeloDysplastic Syndrome (P-MDS)

Myelodysplastic Syndromes · Myelodysplastic Anemia · Myelodysplastic Syndrome With Isolated Del(5Q)

Abroad (travel likely)Recruiting

Brest, France

Luspatercept for CIA in AML

Chemotherapy-inducing Anemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China